| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.06 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |